Navigation Links
Stratagene to appeal verdict won by Third Wave

La Jolla, Calif. -- Stratagene Corp. will appeal the jury verdict that Madison-based Third Wave Technologies won against the California company last week.

Stratagene on Saturday announced its move in response to the decision rendered last Wednesday in the United States District Court for the Western District of Wisconsin. The jury awarded Third Wave......

Full article >>> re and seeks monetary damages as well as a permanent injunction against Third Wave for the sale of its Invader Plus products.

......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 09/05/05


Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
3. Stratagene to pay Third Wave $10.75M in patent case
4. Stratagene sets aside $21M to pay Third Wave pending appeal
5. Stratagene files patent suit against Third Wave
6. Third Wave files patent infringement suit against Stratagene
7. Simplicity appeals to CIOs, but its no easy task
8. Wireless networking appeals to cities around Milwaukee
9. Shorter name appeals to more online visitors for Madison firm
10. Third Wave files countersuit vs. Digene in patent case
11. Third Wave reports net loss of $18.9M for 2006
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... , Feb. 24, 2017 Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... the deadline to participate in its previously announced ... consisting of shares of common stock and Series ... holders of listed warrants. As ...
(Date:2/24/2017)... Feb. 24, 2017 Symic Bio, a biopharmaceutical ... new category of therapeutics, announced today the completion of ... peripheral artery disease. The trial will evaluate the safety ... in the reduction of restenosis following angioplasty. ... milestone for SB-030," said Nathan Bachtell , M.D., ...
(Date:2/24/2017)... KONG, Feb. 24, 2017 China Cord Blood Corporation ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its unaudited financial results for the third ... ended December 31, 2016. Third Quarter of ... third quarter of fiscal 2017 increased by 18.6% to ...
Breaking Biology Technology:
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market Intelligence ... Biometrics and Digital Identity".  Acuity characterizes 2017 as ... when increased adoption reflects a new understanding of ... "Biometrics and digital identity are often perceived ... Maxine Most , Principal of Acuity Market intelligence. ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
Breaking Biology News(10 mins):